Trade OBIO stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Orchestra BioMed Holdings, Inc. (OBIO) is trading at US$6.08, up 5.19% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$322.16M. Over the past 52 weeks, OBIO has traded between US$2.20 and US$6.30. On Syfe you can trade OBIO with $0 commission and add it to your watchlist.
| Previous close | US$5.78 |
|---|---|
| Market cap | US$322.16M |
| 52-week range | US$2.20 – US$6.30 |
| Volume | 1.14M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Orchestra BioMed Holdings, Inc.
Orchestra Biomed Holdings, Inc. engages in the provision of biomedical technologies to patients through risk-reward-sharing partnerships with medical device companies. The company was founded by David P. Hochman on May 25, 2020 and is headquartered in New Hope, PA.
Year: 2023
Orchestra BioMed Holdings, Inc. (OBIO) stock is trading at US$6.08, +5.19% from the previous close of US$5.78.
The market cap for Orchestra BioMed Holdings, Inc. (OBIO) stock is approximately US$322.16M.
The 52-week high for Orchestra BioMed Holdings, Inc. (OBIO) stock is US$6.30.
The 52-week low for Orchestra BioMed Holdings, Inc. (OBIO) stock is US$2.20.
Orchestra BioMed Holdings, Inc. (OBIO) does not currently pay a dividend.
Stay on top of OBIO
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
